China International Capital Corp.

China International Capital raised its price target on Mindray Medical (NYSE: MR) from $37.00 to $44.00 and maintained a Buy rating on the stock. In the report, China International Capital stated, "Management shed more light on the 2013 outlook, where China and Emerging markets will remain the...

According to a research report this morning, China International Capital Corporation Limited upgrades Giant Interactive (NYSE: GA) to Accumulate and adjusts the PT to $6 following strong 1Q12 results and new features and products in the making. China International Capital Corporation Limited...

In a report published earlier today, China International Capital Corporation Limited reiterated its Buy rating for Mindray Medical International Limited (NYSE: MR) and raised its price target from $31.50 to $35.00. CICC went on to say “In 1Q, Mindray acquired a controlling stake of Hangzhou Optcla...

According to a research report published today, CICC has downgraded VanceInfo Technology's (NYSE: VIT) shares from Buy to Hold. In the report, CICC commented, “The company needs to continue investing in financial services so that that area can significantly contribute to profit from 2H12.Therefore...

China International Capital released a report on MecoxLane this morning. In the report, CICC was mixed. CICC writes, “We expect slow revenue growth in 2011 with the possibility of huge losses due to mounting transitional pressures. If it can strengthen its brand image and improve platform...

The Wall Street Journal reported that Morgan Stanley (NYSE: MS) is close to finalizing a deal with Kohlberg Kravis Roberts & Co. and TPG Capital to sell its stake in China International Capital Corp. Morgan Stanley invested $35 million for a 35% stake in the Chinese investment banking joint...